205 related articles for article (PubMed ID: 15718453)
1. Medicine. Race and reification in science.
Duster T
Science; 2005 Feb; 307(5712):1050-1. PubMed ID: 15718453
[No Abstract] [Full Text] [Related]
2. "Racially-tailored" medicine unraveled.
Hoffman S
Am Univ Law Rev; 2005 Dec; 55(2):395-452. PubMed ID: 16619445
[No Abstract] [Full Text] [Related]
3. Genotyping the future: scientists' expectations about race/ ethnicity after BiDil.
Tutton R; Smart A; Martin PA; Ashcroft R; Ellison GT
J Law Med Ethics; 2008; 36(3):464-70. PubMed ID: 18840237
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and ethnically targeted therapies: racial drugs need to be put in context.
Kahn JD
BMJ; 2005 Jun; 330(7506):1508; author reply 1508. PubMed ID: 15976430
[No Abstract] [Full Text] [Related]
5. A race-based detour to personalized medicine.
Collier R
CMAJ; 2012 Apr; 184(7):E351-3. PubMed ID: 22410380
[No Abstract] [Full Text] [Related]
6. Question: does isosorbide dinitrate/hydralazine therapy benefit systolic heart failure patients with renal insufficiency?
Pan L; Payne J; Clark M
J Okla State Med Assoc; 2011 Feb; 104(2):49-50. PubMed ID: 21815321
[No Abstract] [Full Text] [Related]
7. U.S. to review drug intended for one race.
Saul S
N Y Times Web; 2005 Jun; ():A1, A15. PubMed ID: 15966118
[No Abstract] [Full Text] [Related]
8. Clustering humans: on biological boundaries.
Lorusso L; Boniolo G
Stud Hist Philos Biol Biomed Sci; 2008 Mar; 39(1):163-70. PubMed ID: 18331963
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and ethnically targeted therapies.
Rahemtulla T; Bhopal R
BMJ; 2005 May; 330(7499):1036-7. PubMed ID: 15879369
[No Abstract] [Full Text] [Related]
10. Colour-coded cures.
Kingsland J
New Sci; 2005 Jun 11-17; 186(2503):42-7. PubMed ID: 16178100
[No Abstract] [Full Text] [Related]
11. Pharmacogenetics: more than skin deep.
McLeod HL
Nat Genet; 2001 Nov; 29(3):247-8. PubMed ID: 11687789
[No Abstract] [Full Text] [Related]
12. In genetic control of disease, does 'race' matter?
Goldstein DB; Hirschhorn JN
Nat Genet; 2004 Dec; 36(12):1243-4. PubMed ID: 15565101
[No Abstract] [Full Text] [Related]
13. The case of BiDil: a policy commentary on race and genetics.
Carlson RJ
Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-464-8. PubMed ID: 16219648
[TBL] [Abstract][Full Text] [Related]
14. Ancestry estimation and correction for population stratification in molecular epidemiologic association studies.
Barnholtz-Sloan JS; McEvoy B; Shriver MD; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):471-7. PubMed ID: 18349264
[No Abstract] [Full Text] [Related]
15. Genetics. FDA races in wrong direction.
Haga SB; Venter JC
Science; 2003 Jul; 301(5632):466. PubMed ID: 12881555
[TBL] [Abstract][Full Text] [Related]
16. Race: a genetic melting-pot.
Feldman MW; Lewontin RC; King MC
Nature; 2003 Jul; 424(6947):374. PubMed ID: 12879045
[No Abstract] [Full Text] [Related]
17. Race in a bottle. Drugmakers are eager to develop medicines targeted at ethnic groups, but so far they have made poor choices based on unsound science.
Kahn J
Sci Am; 2007 Aug; 297(2):40-5. PubMed ID: 17894171
[No Abstract] [Full Text] [Related]
18. Hydralazine and nitrates: beyond race and ethnicity.
Ghali JK
J Card Fail; 2007 Apr; 13(3):238. PubMed ID: 17448423
[No Abstract] [Full Text] [Related]
19. PGX: Pharmacogenomics During Generation X.
Yee J
Adv Chronic Kidney Dis; 2016 Mar; 23(2):57-60. PubMed ID: 26979142
[No Abstract] [Full Text] [Related]
20. The implications of population admixture in race-based drug prescription.
Suarez-Kurtz G
Clin Pharmacol Ther; 2008 Mar; 83(3):399-400; author reply 400. PubMed ID: 18043692
[No Abstract] [Full Text] [Related]
[Next] [New Search]